Breaking News from #CICON 2023: The ARTIDIS poster unveiled: “Harnessing Nanomechanical Stroma Remodulation to Overcome Resistance to Immunotherapy.” Our research focuses on the convergence of Physics and aid to bedside diagnosis in collaboration w/@MDAndersonNews#EndCancer
Our STIMIT I paper (https://t.co/lq545bwXU1) was nominated "Paper of the Year of the Translational Biology Section of ESICM". https://t.co/UQ7GQoUbVN #ESICM#LIVES2023#STIMIT
Our STIMIT II feasibility study using non-invasive phrenic nerve stimulation in critically ill patients presented at #LIVES2023. Read our STIMIT I study which will be presented in the TV studio on Wed as Paper of the year by the Translational Section: https://t.co/mM1huzVB9A
Our scoping review about exercise therapy in prehabilitation of elderly people with frailty is available. https://t.co/nfCAJL8qsu #prehabilitation#frailty
Welcome to Prof Stefan Schaller MD, Dept of Anesthesiology and Operative Intensive Care Medicine (CVK/CCM),
@ChariteBerlin and School of Medicine @TU_Muenchen 🇩🇪, as new Associate Editor of @yourICM!
📱Follow @DrStefan2 on twitter...
🖋️& submit abstracts https://t.co/HPuWXlP768
On May 9th, 2022, Ewan Goligher @ecgoligher will cover the topic of ventilator-induced diaphragm dysfunction. Here to the webinar: https://t.co/QWHOkqU8tD
On May 9th, 2022, Ewan Goligher @ecgoligher will cover the topic of ventilator-induced diaphragm dysfunction. Here to the webinar: https://t.co/QWHOkqU8tD
#SozialeInnovationen gehören in allen Ländern auf die politische Agenda! Unsere Beauftragte @ZarahBruhn hat in #Paris diskutiert, wie sich Soziale Innovationen in der @OECD fördern lassen. https://t.co/gLw6tLzj3F
72 Anträge – ein Erfolg auf ganzer Linie für die erste Förderrichtlinie von „Gesellschaft der Innovationen“! Wir freuen uns mit @ZarahBruhn über so viel Resonanz aus dem Hochschulraum für Fort- und Weiterbildungsinstrumente im Feld #SozialeInnovationen und #Sozialunternehmen.